-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Alibaba Health Information Technology Limited (HKG:241) Insiders Placed Bullish Bets Worth CN¥8.7m in the Last 12 Months
Alibaba Health Information Technology Limited (HKG:241) Insiders Placed Bullish Bets Worth CN¥8.7m in the Last 12 Months
In the last year, multiple insiders have substantially increased their holdings of Alibaba Health Information Technology Limited (HKG:241) stock, indicating that insiders' optimism about the company's prospects has increased.
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
See our latest analysis for Alibaba Health Information Technology
Alibaba Health Information Technology Insider Transactions Over The Last Year
In the last twelve months, the biggest single purchase by an insider was when COO & Executive Director Difan Shen bought HK$4.5m worth of shares at a price of HK$7.54 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being HK$4.70). While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Notably Difan Shen was also the biggest seller.
Over the last year, we can see that insiders have bought 1.17m shares worth HK$8.7m. But insiders sold 21.39k shares worth HK$108k. In total, Alibaba Health Information Technology insiders bought more than they sold over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
SEHK:241 Insider Trading Volume August 15th 2022Alibaba Health Information Technology is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
Insiders At Alibaba Health Information Technology Have Sold Stock Recently
We have seen a bit of insider selling at Alibaba Health Information Technology, over the last three months. Insiders sold just HK$108k worth of shares in that time. It's not great to see insider selling, nor the lack of recent buyers. But the selling simply isn't sufficiently substantial to be of much use as a signal.
Insider Ownership Of Alibaba Health Information Technology
For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It's great to see that Alibaba Health Information Technology insiders own 5.8% of the company, worth about HK$3.7b. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
So What Do The Alibaba Health Information Technology Insider Transactions Indicate?
Insiders sold Alibaba Health Information Technology shares recently, but they didn't buy any. On the other hand, the insider transactions over the last year are encouraging. We are also comforted by the high levels of insider ownership. So we're happy to look past recent trading. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Every company has risks, and we've spotted 1 warning sign for Alibaba Health Information Technology you should know about.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
去年,多家内部人士大幅增持了阿里健康有限公司(HKG:241)股票,显示内部人士对公司前景的乐观情绪有所增加。
尽管就长期投资而言,内幕交易并不是最重要的事情,但从逻辑上讲,你应该关注内部人士是在买入还是卖出股票。
参见我们对阿里健康的最新分析
阿里健康过去一年的内幕交易
过去12个月,内部人士买入的最大单笔交易是董事首席运营官沈迪凡以每股7.54港元的价格购入价值450万港元的股票。因此,很明显,一名内部人士想要收购,即使价格高于目前的股价(4.70港元)。尽管他们的观点可能在收购后发生了变化,但这至少表明他们对公司的未来充满信心。我们总是仔细注意内部人士购买股票时支付的价格。一般来说,如果内部人士以高于当前价格的价格买入一只股票,我们对这只股票的看法会更积极,因为这表明他们认为这只股票很有价值,即使价格更高。值得注意的是,沈迪凡也是最大的卖家。
过去一年,我们可以看到,内部人士购买了117万股股票,价值870万港元。但内部人士抛售了21.39万股,价值10.8万港元。过去一年,阿里健康内部人士总共买多卖少。你可以在下面看到过去12个月(由公司和个人)进行的内幕交易的直观描述。如果你想知道到底是谁卖了,卖了多少钱,什么时候卖的,只需点击下面的图表!
联交所:241宗内幕交易量2022年8月15日内部人士买入的股票并非只有阿里健康一只。对于那些想要找到赢得投资这免费最近有内幕收购的不断增长的公司名单可能就是合适的选择。
阿里健康的内部人士最近抛售了股票
在过去的三个月里,我们看到了阿里健康的一些内幕出售行为。在此期间,内部人士仅出售了价值10.8万港元的股票。看到内幕销售或缺少最近的买家都不是件好事。但抛售的规模还不够大,不足以作为一个信号发挥作用。
阿里健康的内部人所有权
对于一个普通股股东来说,公司内部人士持有多少股份值得一查。通常,内部人持股越高,内部人就越有可能受到激励,建立长期的公司。很高兴看到阿里健康的内部人士持有该公司5.8%的股份,价值约37亿港元。大多数股东将乐于看到这种内部人持股,因为这表明管理层的激励与其他股东很好地结合在一起。
那么,阿里健康内幕交易意味着什么呢?
内部人士最近卖出了阿里健康的股票,但他们一股也没买。另一方面,过去一年的内幕交易令人鼓舞。我们还对高水平的内部人持股感到欣慰。因此,我们很高兴回顾一下最近的交易。因此,这些内幕交易可以帮助我们建立一个关于股票的论文,但了解这家公司面临的风险也是值得的。每家公司都有风险,我们已经发现阿里健康的1个警示标志你应该知道。
如果你更愿意看看另一家公司--一家财务状况可能更好的公司--那么不要错过这一点免费列出了一些有趣的公司,这些公司拥有高股本回报率和低债务。
就本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前负责公开市场交易和私人处置,但不包括衍生品交易。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧